Glendale, CA – According to filings with the U.S. Securities and Exchange Commission, Fluxa is raising $5,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Suraj Pai played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Fluxa

Our mission is to accelerate the speed to market for new therapies by helping drug development and manufacturing organizations harness the power of collaboration and data across sites, functions, and processes. We do this by providing software that is user-focused, domain-specific, and built on the latest digital technologies. Our deep understanding of how life science companies develop and manufacture drugs means that our applications are designed to fit seamlessly into the drug development and manufacturing process. Our products are based on modern technology architectures that enable easy scaling and provide the flexibility to integrate with other systems, giving your organization a holistic way of managing a drug’s lifecycle. We are a team of digital transformation experts with a track record of leveraging leading edge technologies related to advanced analytics and artificial intelligence, to change how life science companies operate.

To learn more about Fluxa, visit http://www.fluxa.io/

Contact:
Suraj Pai, Chief Executive Officer
866-993-5892
suraj@fluxa.io
https://www.linkedin.com/in/surajpai/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved